-
MS417
- names:
GTPL7512
- CAS号:
916489-36-6
MDL Number: - MF(分子式): C20H19ClN4O2S MW(分子量): 414.91
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM000665-10mg | 10mg | 99.51% | ¥ 4725.00 | ¥ 4725.00 | 2-3天 | ¥ 0.00 | ||
| YZM000665-5mg | 5mg | 99.51% | ¥ 3250.00 | ¥ 3250.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | 甲基2-((6S,Z)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-f] [1,2,4]三唑[4,3-a ] [1,4]二氮杂-1-基乙酸酯 |
| 英文别名 | Methyl-[(6S)-4-(4-chlorphenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetat |
| CAS号 | 916489-36-6 |
| Inchi | InChI=1S/C20H19ClN4O2S/c1-10-11(2)28-20-17(10)18(13-5-7-14(21)8-6-13)22-15(9-16(26)27-4)19-24-23-12(3)25(19)20/h5-8,15H,9H2,1-4H3/t15-/m0/s1 |
| InchiKey | GGRCIHACOIMRKY-HNNXBMFYSA-N |
| 分子式 Formula | C20H19ClN4O2S |
| 分子量 Molecular Weight | 414.91 |
| 溶解度Solubility | 生物体外In Vitro:Ethanol : 50 mg/mL(120.51 mM;Need ultrasonic) |
| 性状 | Solid |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
MS417(CAS:916489-36-6)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
MS417(CAS:916489-36-6)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | MS417 为 BET 特异性蛋白BRD4的抑制剂,能够与 BRD4-BD1 和 BRD4-BD2 结合,IC50值分别为 30,46 nM,Kd值分别为 36.1,25.4 nM; MS417 对 CBP BRD 的选择性较低,IC50值为 32.7 μM |
| Introduction | MS417 is a BETpecificBRD4inhibitor, binds to BRD4D1 and BRD4D2 withIC50s of 30, 46 nM andKds of 36.1, 25.4 nM, respectively, with weak selectivity at CBP BRD (IC50, 32.7 μM). |
| Application1 | |
| Application2 | |
| Application3 |
MS417 为 BET 特异性蛋白BRD4的抑制剂,能够与 BRD4-BD1 和 BRD4-BD2 结合,IC50值分别为 30,46 nM,Kd值分别为 36.1,25.4 nM; MS417 对 CBP BRD 的选择性较低,IC50值为 32.7 μM。
MS417 is a BET-specificBRD4inhibitor, binds to BRD4-BD1 and BRD4-BD2 withIC50s of 30, 46 nM andKds of 36.1, 25.4 nM, respectively, with weak selectivity at CBP BRD (IC50, 32.7 μM).
MS417 (also known as GTPL7512) is a potent and selective BRD4 inhibitor, which binds to BRD4-BD1 and BRD4-BD2 with IC50s of 30 and 46 nM, respectively. MS417 effectively blocks BRD4 binding to NF-κB, almost completely suppresses TNFα-induced NF-κB transcription activation in human embryonic kidney 293T cells at 1 μM and also reduces NF-κB p65 acetylation in the HIV-infected RTECs. MS417 (1 μM) modulation of gene transcription in HIV-infected human primary renal tubular epithelial cells.
In vivo, MS417 (0.08 mg/kg) markedly improves renal function, reduces proteinuria and decreases glomerulosclerosis, tubular injury, and infiltration of inflammatory cells in the kidney of Tg26 mice.
MS417 is a BET-specificBRD4inhibitor, binds to BRD4-BD1 and BRD4-BD2 withIC50s of 30, 46 nM andKds of 36.1, 25.4 nM, respectively, with weak selectivity at CBP BRD (IC50, 32.7 μM).
MS417 (also known as GTPL7512) is a potent and selective BRD4 inhibitor, which binds to BRD4-BD1 and BRD4-BD2 with IC50s of 30 and 46 nM, respectively. MS417 effectively blocks BRD4 binding to NF-κB, almost completely suppresses TNFα-induced NF-κB transcription activation in human embryonic kidney 293T cells at 1 μM and also reduces NF-κB p65 acetylation in the HIV-infected RTECs. MS417 (1 μM) modulation of gene transcription in HIV-infected human primary renal tubular epithelial cells.
In vivo, MS417 (0.08 mg/kg) markedly improves renal function, reduces proteinuria and decreases glomerulosclerosis, tubular injury, and infiltration of inflammatory cells in the kidney of Tg26 mice.
| Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. Zhang G, et al. J Biol Chem. 2012 Aug 17;287(34):28840-51. PMID: 22645123. |
【1】.Zhang G, et al. Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. J Biol Chem. 2012 Aug 17;287(34):28840-51.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


